Trial site
Barts Health NHS Trust St Bartholomew's Hospital
- 6running trials
- 6closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer3 trials
- Metastatic breast cancer3 trials
- Kidney cancer2 trials
- Lung cancer2 trials
- Triple-negative breast cancer2 trials
- Colorectal cancer1 trial
- Coronary artery disease1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Hypertrophic cardiomyopathy1 trial
- Melanoma1 trial
- Phase
- Phase 35 trials
- Phase 23 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Completed6 trials
- Active, not recruiting4 trials
- Recruiting2 trials
- Lead sponsor
- Hoffmann-La Roche2 trials
- ALX Oncology Inc.1 trial
- Cytokinetics1 trial
- Eisai Inc.1 trial
- European Organisation for Research and Treatment of Cancer - EORTC1 trial
- and 6 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Study With Various Immunotherapy Treatments in Participants With Lung Cancer
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Recruiting
Active, not recruiting
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Completed
Follow-up in Early and Locally Advanced Breast Cancer Patients
Completed
Recruiting
Completed
Completed
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026